Status:
COMPLETED
Esmolol in Cardiac Surgery
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.
Eligibility Criteria
Inclusion
- end diastolic diameter \>60 mm and/or an ejection fraction \<50%
- written informed consent
- age \>18 years
Exclusion
- previous unusual response to esmolol
- inclusion in other randomized studies
- esmolol administration in the previous 30 days
- emergency operation
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00959569
Start Date
August 1 2009
End Date
June 1 2018
Last Update
October 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vita-Salute University
Milan, Italy